Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Moodys
Express Scripts
Mallinckrodt

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

ZITHROMAX Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Zithromax patents expire, and what generic alternatives are available?

Zithromax is a drug marketed by Pfizer and is included in seven NDAs.

The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the azithromycin profile page.

Drug patent expirations by year for ZITHROMAX
Drug Prices for ZITHROMAX

See drug prices for ZITHROMAX

Drug Sales Revenue Trends for ZITHROMAX

See drug sales revenues for ZITHROMAX

Recent Clinical Trials for ZITHROMAX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 3
Patient-Centered Outcomes Research InstitutePhase 3
Federal Medical Centre, OwoN/A

See all ZITHROMAX clinical trials

Recent Litigation for ZITHROMAX

Identify potential future generic entrants

District Court Litigation
Case NameDate
Pfizer Inc v. Teva Pharmaceuticals USA2006-02-08

See all ZITHROMAX litigation

Pharmacology for ZITHROMAX
Synonyms for ZITHROMAX
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-((2S,3R,4S,6R)-
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6
[2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*)]-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-
104491-80-7
117772-70-0
117772-70-0 (dihydrate)
121470-24-4 (monohydrate)
142556-82-9
24238-EP2295402A2
24238-EP2314590A1
24238-EP2380874A2
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
9-Deoxy-9a-aza-9a-methyl-9a-homoerythromycin A
905A015
A-9940
A-9941
AB00698251_11
AB00698251-10
AC-16014
AC1L9KEG
ACT03224
AKOS015895044
Aritromicina
Aritromicina [Spanish]
Aycin
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
azithromycin
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin (Zithromax)
Azithromycin [USAN:INN:BAN]
AZITHROMYCIN DIHYDRATE
Azithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Azithromycin for system suitability, European Pharmacopoeia (EP) Reference Standard
Azithromycin Identity, United States Pharmacopeia (USP) Reference Standard
Azithromycin, analytical standard
Azithromycin, Antibiotic for Culture Media Use Only
Azithromycin, European Pharmacopoeia (EP) Reference Standard
Azithromycin,(S)
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromicine
Azitromin
Aziwok
AZM
Aztrin
Azyter
Azythromycin
BC204085
BDBM50373918
BIDD:GT0792
BRD-K74501079-001-18-1
BRN 5387583
BSPBio_002285
C38H72N2O12
CAS-83905-01-5
CCG-39360
CCRIS 1961
CHEBI:2955
CHEMBL3736045
CHEMBL529
CP 62993
CP 62993; Zithromax
CP-62993
CP-62993-3
CP62,993
CPD000471864
CS-2308
DB00207
DCH3
DivK1c_000233
DRG-0104
DSSTox_CID_10760
DSSTox_GSID_30760
DSSTox_RID_78858
DTXSID8030760
EBD2198275
EC 617-500-5
GTPL6510
Hemomycin
HMS1922G12
HMS2094M11
HMS2232M10
HMS3259D10
HMS500L15
HSDB 7205
HY-17506
IDI1_000233
J2KLZ20U1M
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MCULE-8817893418
Misultina
Mixoterin
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
MolPort-002-507-426
MQTOSJVFKKJCRP-BICOPXKESA-N
NC00712
NCGC00090753-01
NCGC00090753-02
NCGC00090753-03
NCGC00090753-04
NCGC00258564-01
NINDS_000233
NSC643732
SAM002589961
SBI-0206706.P001
SCHEMBL23481
Setron
SMR000471864
SPBio_001544
Spectrum_000307
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
SR-05000002067
SR-05000002067-1
SR-05000002067-2
Sumamed
SYN3010
Tobil
Tox21_111008
Tox21_201011
Tromix
Trulimax
UNII-F94OW58Y8V component MQTOSJVFKKJCRP-BICOPXKESA-N
UNII-J2KLZ20U1M
XZ-450
Z-Pak
Z-Pak (Azithromycin)
Z1563146014
Zentavion
Zeto
Zifin
ZINC85537026
ZIT
Zithrax
Zithromac
Zithromax IV
Zithromax, Azithrocin, Azin
Zithromycin
Zitrim
Zitromax
Zitromax Avium 600
Zitrotek
Zmas
Zmax
Zmax SR

US Patents and Regulatory Information for ZITHROMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ZITHROMAX azithromycin CAPSULE;ORAL 050670-001 Nov 1, 1991 DISCN Yes No   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050784-001 May 24, 2002 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-002 Oct 19, 1995 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050730-001 Jun 12, 1996 DISCN Yes No   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050693-001 Sep 28, 1994 RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-001 Oct 19, 1995 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050711-001 Jul 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZITHROMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050693-001 Sep 28, 1994   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050730-001 Jun 12, 1996   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050711-001 Jul 18, 1996   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-002 Oct 19, 1995   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050784-001 May 24, 2002   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-001 Oct 19, 1995   Start Trial   Start Trial
Pfizer ZITHROMAX azithromycin INJECTABLE;INJECTION 050733-001 Jan 30, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ZITHROMAX
Drugname Dosage Strength RLD Date
➤ Subscribe For Injection 500 mg/vial ➤ Subscribe   Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Moodys
Boehringer Ingelheim
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.